KEY MARKETING ASPECTS
- managing one of the most common childhood illnesses
- proprietary synbiotic containing the probiotic strain Bifidobacterium animalis ssp. lactis and the prebiotic inulin
- significant reduction of diarrhea duration
- outperforms S. boulardii
- clinically tested in infants and children (2 – 60 month)
- pharmacy exclusive
- tests demonstrated enhancement of growth and persistency of Bifidobacterium animalis ssp.